Maximizing the Benefit of Renin-Angiotensin Blocking Drugs in Diabetic Renal Disease.
This study has been completed.
Sponsor:
Stanford University
Collaborator:
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00240019
First received: October 13, 2005
Last updated: October 16, 2006
Last verified: June 2006
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | April 2006 |
| Estimated Primary Completion Date: | No date given |